New plasmid-mediated aminoglycoside adenylyltransferase of broad substrate range that adenylylates amikacin.
AUTOR(ES)
Coombe, R G
RESUMO
The same aminoglycoside 2"-adenylyltransferase was isolated from four gram-negative species which were among a random group of gentamicin-resistant isolates from the same hospital. The enzyme was partially purified from a crude extract which also contained a second modifying enzyme identified as APH(3')-I. The substrate range of the new aminoglycoside 2"-adenylyltransferase included the newer aminoglycosides sisomicin and amikacin, but showed much-reduced activity against gentamicins C2 and Cla. The pH optimum was 7.8 to 8.0 for every substrate, and the molecular weight of the enzyme molecule was estimated at approximately 29,000. Genetic experiments clearly established that both enzymes were expressed by a conjugative plasmid.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181636Documentos Relacionados
- Plasmid-Mediated Aminoglycoside Phosphotransferase of Broad Substrate Range That Phosphorylates Amikacin
- New Plasmid-Mediated Nucleotidylation of Aminoglycoside Antibiotics in Staphylococcus aureus
- Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi.
- TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
- Evidence of plasmid-mediated production of aminoglycoside-modifying enzymes not previously described in Acinetobacter.